Cite
HARVARD Citation
Yuan, Z. et al. (2020). Acute pancreatitis risk in type 2 diabetes patients treated with canagliflozin versus other antihyperglycemic agents: an observational claims database study. Current medical research and opinion. pp. 1117-1124. [Online].